What about his qualifications?...I'm insinuating nothing...he's a research analyst and like all research analysts, he writes research reports which are paid for by the company
You keep asking me to add value....let's get some value from you...Tell us why you believe it is seriously undervalued? I'll be very interested to learn
- Forums
- ASX - By Stock
- IIQ
- New valuation - $3.25 SP
New valuation - $3.25 SP, page-11
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 43.0¢ | $18.17K | 41.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 52546 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 24522 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 52546 | 0.435 |
2 | 6333 | 0.430 |
5 | 44773 | 0.425 |
1 | 10000 | 0.410 |
3 | 24814 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 24522 | 1 |
0.460 | 6850 | 1 |
0.465 | 1195 | 1 |
0.470 | 35663 | 2 |
0.480 | 40000 | 2 |
Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online